Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:09 PM
Study NCT ID:
NCT05028556
Status:
COMPLETED
Last Update Posted:
2025-07-20
First Post:
2021-08-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors
Sponsor:
Wuhan YZY Biopharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-25
First Submit QC Date:
None
Study First Post Date:
2021-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-16
Last Update Post Date:
2025-07-20
Last Update Post Date Type:
ACTUAL